Ibuvit D3

Colecalciferol, the active ingredient in Ibuvit D3, is a vitamin D presented as an oral supplement for oral use. It is used to address vitamin D deficiency and support bone health in individuals with insufficient dietary intake or limited sun exposure.

GNH USA supplies Ibuvit D3 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuvit D3 (colecalciferol) is used to correct deficiencies in the vitamin D pathway and support calcium metabolism.

- Vitamin D deficiency: restores adequate serum 25‑hydroxyvitamin D levels. - Osteoporosis or low bone mass: supports bone mineralization and reduces fracture risk. - Hypocalcemia: helps maintain normal calcium and phosphate concentrations in the blood.

Common Side Effects: - Nausea: mild stomach upset may occur. - Constipation: occasional difficulty passing stool. - Dry mouth: reduced salivation reported. - Headache: transient mild headache.

Serious or Rare Side Effects: - Hypercalcemia: elevated blood calcium with symptoms such as weakness or arrhythmia. - Kidney stones: calcium deposition in the urinary tract. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Cardiac arrhythmia: irregular heartbeat in cases of extreme toxicity.

Before initiating therapy, consider the following precautions: - Baseline assessment: evaluate serum calcium and 25‑hydroxyvitamin D levels. - Monitoring: watch for signs of hypercalcemia during treatment. - Renal impairment: adjust dose or frequency in patients with reduced kidney function. - Concomitant calcium: avoid high‑dose calcium supplements unless medically indicated. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Colecalciferol may interact with several medicines. Review the following:

Major Interactions (Avoid): - Thiazide diuretics: increase risk of hypercalcemia. - Excess vitamin A: synergistic hypercalcemia potential. - Aluminum‑containing antacids: reduce vitamin D absorption. - High‑dose calcium supplements: may precipitate hypercalcemia.

Moderate Interactions (Monitor Closely): - Corticosteroids: may diminish vitamin D effectiveness. - Orlistat: can decrease absorption of fat‑soluble vitamins. - Phenobarbital and phenytoin: accelerate vitamin D metabolism, possibly lowering efficacy.